Monitor upcoming clinical data readouts for CG Oncology's pipeline; the divergence between active accumulators (American Century, D.E. Shaw) and mega-passive trimmers (BofA, Goldman, UBS) suggests the stock's next move hinges on binary catalyst events rather than fundamental drift.
Executive Summary
CG Oncology saw mixed institutional activity in Q2 2026, with 33 buyers adding $166.7M and 22 sellers reducing $129.2M. Notable active managers like American Century Companies and D.E. Shaw increased positions, while Point72 fully exited and several mega-passive funds trimmed. The net signal is mixed, reflecting uncertainty around the company's clinical-stage pipeline.
Key Financial Metrics
Institutional Positions
Net institutional flow: $37.5M
▲ Buyers (33)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| American Century Companies | DOUBLED | +14698.3% | $51.6M | $51.3M |
| Morgan Stanley | DOUBLED | +126.3% | $83.6M | $48.4M |
| Geode | ADD | +34.8% | $153.0M | $44.9M |
| D.E. Shaw | ADD | +91.8% | $6.4M | $3.2M |
▼ Sellers (22)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Point72 | EXIT | -100% | $27.0M | -$27.0M |
| BofA | TRIM | -32% | $98.1M | -$28.1M |
| UBS | TRIM | -25.5% | $88.8M | -$19.3M |
| Goldman Sachs | TRIM | -26% | $78.5M | -$17.5M |
Key Facts
- 33 institutional buyers added $166.7M in aggregate; 22 sellers reduced $129.2M
- American Century Companies DOUBLED its position (+14,698% shares) to $51.6M
- Morgan Stanley DOUBLED to $83.6M; Geode ADDED to $153.0M
- Point72 fully exited a $27.0M position
- BofA trimmed $28.1M; UBS trimmed $19.3M; Goldman Sachs trimmed $17.5M
- Net aggregate buying of $37.5M across all tracked institutions
Financial Impact
Net institutional accumulation of $37.5M (buyers added $166.7M, sellers reduced $129.2M) in Q2 2026
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- Pre-revenue clinical-stage biotech with binary pipeline risk
- Point72's full exit signals potential thesis concern from a sophisticated quant fund
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CGON-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 3 | $61.93 | awaiting T+20 | — | — |
Oct 15, 2026 11d ago | 144 | $59.85 | awaiting T+20 | — | — |
Oct 12, 2026 15d ago | Institutional Cluster | $63.13 | awaiting T+20 | — | — |
Aug 6, 2026 11w ago | Press Release | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | — |
Aug 6, 2026 11w ago | 424B5 | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | — |
Jul 27, 2026 13w ago | Press Release | $72.62 $78.95 | ▲ +8.72% | ▲ +5.34% | — |
Jul 17, 2026 14w ago | Insider Cluster | $70.19 $77.11 | ▲ +9.86% | ▲ +5.74% | — |
Jul 16, 2026 14w ago | Court Ruling | $71.85 $75.03 | ▲ +4.43% | ▼ −0.02% | — |
Jun 24, 2026 17w ago | 144 | $72.84 $71.12 | ▼ −2.36% | ▼ −2.89% | — |
Jun 22, 2026 18w ago | 144 | $65.73 $70.19 | ▲ +6.79% | ▲ +5.63% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers